NANA – Registry-based non-randomized studies for assessing the benefits and harms of drugs

Department of Medical Statistics

The research team in the NANA project is investigating whether it is currently possible and sensible to use the registry data available in Germany for assessing the benefits and harms of new drugs. 

For this purpose, the team is carrying out ten to twelve register-based non-randomized studies. The results of these analyses will be compared with the existing results on the same clinical question from randomised controlled trials.

The project aims to provide insights into the circumstances under which an analysis based on routinely collected data can provide reliable results on the benefits and harms of drugs and which aspects need to be carefully considered when such analyses are implemented.

The project is funded by the “Federal Joint Committee”. Find here the project description of the “Innovationsausschuss”.

Given talks and presentations

As part of the NANA project, the following presentations and talks were given:

Contact

Leitung

Univ.-Prof. Dr. Tim Friede

Univ.-Prof. Dr. Tim Friede

contact information

more
Wissenschaftlicher Mitarbeiter

Omar Ammous, M.D.

 Omar Ammous, M.D.

contact information

more
Datenmanager

Enes Malik Cakir, MSc

contact information

more
Wissenschaftliche Mitarbeiterin

Dr. Regina Kampo

Dr. Regina Kampo

contact information

more
Wissenschaftliche Mitarbeiterin

Susanna Salem, MSc

 Susanna Salem, MSc

contact information

more
Doktorandin

Maxi Schulz, MSc

 Maxi Schulz, MSc

contact information

more
Wissenschaftliche Mitarbeiterin

Paula Starke, MSc

 Paula Starke, MSc

contact information

more

Follow us